International Journal of Antimicrobial Agents
Volume 35, Issue 6 , Pages 559-565, June 2010

In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections

  • Andrew P. Desbois

      Affiliations

    • Biomedical Sciences Research Complex, School of Biology, University of St Andrews, The North Haugh, Fife KY16 9ST, UK
    • ,
  • Curtis G. Gemmell

      Affiliations

    • Bute Medical Building, School of Medicine, University of St Andrews, Fife KY16 9TS, UK
    • ,
  • Peter J. Coote

      Affiliations

    • Biomedical Sciences Research Complex, School of Biology, University of St Andrews, The North Haugh, Fife KY16 9ST, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 1334 463 406; fax: +44 1334 462 595.

Received 14 December 2009; accepted 14 January 2010. published online 08 March 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0924-8579(10)00061-0

doi:10.1016/j.ijantimicag.2010.01.016

International Journal of Antimicrobial Agents
Volume 35, Issue 6 , Pages 559-565, June 2010

Article Tools

* Image Usage & Resolution